Compared with the control group , the immunoglobulin group had a significantly increased fecal SIgA level after 1 day of treatment ( P < 0.05 ) , significantly decreased frequency of diarrhea and fecal rotavirus shedding after 3 days of treatment ( P < 0.05 ) , and a significantly shorter disease course ( 4.51.0 vs 5.81.7 days ; P < 0.05 ) .